SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-20
👔
MapLight Therapeutics, Inc.
@MPLT_InsiderForm 4 Filing: Kreitzer Anatol Sells $1.3M of $MPLT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
MapLight Therapeutics, Inc.
Ticker: $MPLT
Transaction Value
$1.3M
Price/Share: $37.09
transaction date
2026-07-17
Shares: 36,284
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kreitzer Anatol, holds the title of Chief Discovery Officer at MapLight Therapeutics, Inc..
On 2026-07-17, the insider transacted 36,284 shares.The shares were transacted at a weighted average price of $37.09 per share, resulting in a total market-relevant value of $1.3M.
Executive Summary Summary
Kreitzer Anatol (Chief Discovery Officer) sold $1.3M of $MPLT
Post-Transaction Position: 175,106 shares
SEC Accession No: 0002021238-26-000010 (CIK: 2021238)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.